DaVita Clinical Research (DCR), a wholly-owned subsidiary of DaVita Inc., presented the results of five innovative research projects at the American Society of Nephrology's annual Kidney Week meeting in San Diego, CA. This highlights DaVita's role as a leader in kidney care research.
The research focused on addressing pressing issues in nephrology, including improving racial equity in transplantation and enhancing key measures of clinical quality such as hospitalizations. These efforts align with DaVita's commitment to improving clinical outcomes for diverse patient populations.
Dr. Brunelli, vice president of health analytics and insights at DaVita, stated that the findings support the company's commitment to enhancing upstream Chronic Kidney Disease (CKD) care management, preventing kidney failure, and promoting health equity. This ongoing research contributes to DaVita's competitive edge by advancing clinical quality and care delivery.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.